HB 263

  • Delaware House Bill
  • 150th General Assembly (2019-2020)
  • Introduced in House Feb 28, 2020
  • Passed House Jan 30, 2020
  • Passed Senate Jun 16, 2020
  • Signed by Governor Jul 16, 2020

An Act To Amend Title 18 And Title 29 Of The Delaware Code Relating To Cost Sharing In Prescription Insulin Drugs.

Abstract

This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.

Bill Sponsors (31)

Votes


Jun 16, 2020

Jan 30, 2020

Actions


Jul 16, 2020

Office of the Governor

Signed by Governor

Jun 16, 2020

Senate

Suspension of Rules in Senate

Senate

Passed By Senate. Votes: 21 YES

Feb 28, 2020

Senate

Assigned to Health & Social Services Committee in Senate

  • Introduction
  • Referral-Committee
Health & Social Services

Jan 30, 2020

House

Amendment HA 2 to HB 263 - Stricken in House

House

Amendment HA 1 to HB 263 - Passed In House by Voice Vote

House

Passed By House. Votes: 40 YES 1 ABSENT

Jan 29, 2020

House

Amendment HA 2 to HB 263 - Introduced and Placed With Bill

House

Amendment HA 1 to HB 263 - Introduced and Placed With Bill

Jan 15, 2020

House

Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 4 On Its Merits

  • Committee-Passage-Favorable
  • Committee-Passage
Health & Human Development

Jan 09, 2020

House

Introduced and Assigned to Health & Human Development Committee in House

  • Introduction
  • Referral-Committee
Health & Human Development

Bill Text

Bill Text Versions Format
Bill Text PDF HTML
HA 1 to HB 263 HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Delaware General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.